Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
10.70
-0.46 (-4.12%)
Sep 15, 2026, 4:00 PM EDT - Market closed

Vicore Pharma Holding AB Revenue

Vicore Pharma Holding AB had revenue of 2.21M SEK in the quarter ending June 30, 2026, with 26.75% growth. This brings the company's revenue in the last twelve months to 3.99M, down -48.40% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.

Revenue (ttm)
3.99M SEK
Revenue Growth
-48.40%
P/S Ratio
717.10
Revenue / Employee
86,826 SEK
Employees
46
Market Cap
295.51M USD

Revenue Chart

Chart
* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.82M-105.53M-96.51%
Dec 31, 2024109.35M--
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 2018508.00K-424.00K-45.49%
Dec 31, 2017932.00K80.00K9.39%
Dec 31, 2016852.00K12.00K1.43%
Dec 31, 2015840.00K-11.00K-1.29%
Dec 31, 2014851.00K131.00K18.19%
Dec 31, 2013720.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals215.72M
Fulcrum Therapeutics80.00M
Clinuvel Pharmaceuticals65.05M
Zentalis Pharmaceuticals26.87M
Abeona Therapeutics25.52M
Fate Therapeutics6.49M
Upstream Bio3.16M
SAB Biotherapeutics114.70K
Revenue Rankings

VCRE News

More News